Desq Long
Sign in
SEC FORM 4
$0.00

Iambic Therapeutics, Inc. (IAM)

Acquisition (code A) of 132,200 shares at $0 per share.

Reporting Person Manby Frederick R · Officer Title Chief Technology Officer · Transaction Code A

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0002156015-26-000005 · filed 2026-10-16 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Iambic Therapeutics, Inc. (IAM)." Disclosed 2026-10-16. https://desqlong.com/cards/0002156015-26-000005-1 (retrieved 2026-10-17).